DHG Pharmaceutical JSC (DHG) — Cash Flow Quality Index
DHG Pharmaceutical JSC (DHG) has a Cash Flow Quality Index of 2.42x as of December 2025. Operating cash flow of ₫447.50 Billion exceeds net income of ₫184.80 Billion, indicating high earnings quality where cash backs reported profits. Explore DHG Pharmaceutical JSC (DHG) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DHG Pharmaceutical JSC Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for DHG Pharmaceutical JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DHG total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for DHG Pharmaceutical JSC (2019–2025)
Year-by-year earnings quality comparison for DHG Pharmaceutical JSC. For live market cap and the full company financial profile, see how much is DHG Pharmaceutical JSC worth.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.36x | ₫1.22 Trillion | ₫897.58 Billion | ▼ -19.4% |
| 2024 | 1.69x | ₫1.32 Trillion | ₫778.92 Billion | ▲ +535.5% |
| 2023 | 0.27x | ₫279.88 Billion | ₫1.05 Trillion | ▼ -70.8% |
| 2022 | 0.91x | ₫901.28 Billion | ₫988.45 Billion | ▲ +56.6% |
| 2021 | 0.58x | ₫452.44 Billion | ₫777.22 Billion | ▼ -47.9% |
| 2020 | 1.12x | ₫826.17 Billion | ₫739.87 Billion | ▼ -15.4% |
| 2019 | 1.32x | ₫838.24 Billion | ₫635.39 Billion | — |